Calls for IVF laws to be changed to take advantage of gene editing technique
By Steve Connor,
The Independent
| 09. 02. 2015
Untitled Document
Britain may need to change its IVF laws to allow the genetic modification of human embryos so that scientists can use a gene-editing technique that could eliminate certain inherited diseases, leading biomedical organisations warn.
At present it is illegal to alter the genes of reproductive “germ cells” such as eggs, sperm and embryos, but the clinical benefits of modifying the human germ-line could one day outweigh the ethical objections, says a statement by two government research councils and a coalition of medical research charities.
While the US has imposed a moratorium on the use of genome editing of human embryos, the joint statement implies that the day might soon come in the UK when it is ethically justified to implant the first genetically modified embryo in a womb. The research organisations, which include the Medical Research Council and the Wellcome Trust, Britain’s biggest medical charity, said there was no reason why the gene-editing technique known as Crispr-Cas9 should not be used immediately on early IVF embryos for research purposes provided they are not implanted into the womb –...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...